Latest News of MTX
Minerals Technologies Inc. (NYSE:MTX) Shares Could Be 45% Below Their Intrinsic Value Estimate
By Yahoo! Finance |
1 week ago
An analyst's price target for MTX is $99, 34% below the fair value estimate. Using the Discounted Cash Flow (DCF) model, we project future cash flows of Minerals Technologies Inc. to assess its invest...
Returns On Capital At MTU Aero Engines (ETR:MTX) Have Hit The Brakes
By Yahoo! Finance |
1 week ago
To identify a potential multi-bagger stock, look for increasing Return on Capital Employed (ROCE) and expanding capital base in a business, indicating profitable reinvestment opportunities....
Minerals Technologies Inc. (MTX): An Undervalued Chemical Stock to Invest In Now
By Yahoo! Finance |
3 weeks ago
The chemical industry plays a vital role in various sectors, driving innovation and sustainability. With increasing demand for innovative products, technological advancements, and a focus on sustainab...
-
Minerals Technologies Inc (MTX) Q3 2024 Earnings Call Highlights: Navigating Market Challenges ...
By Yahoo! Finance | 3 weeks agoCEO and executives discuss factors contributing to business segment slowdown, including inventory reductions and demand softening. Potential for margin improvement acknowledged, with new targets to be...
-
BMTX Stock Price | BM Technologies Inc. Stock Quote (U.S.: NYSE American) | MarketWatch
By MarketWatch | 3 weeks agoBM Technologies, Inc. is a tech firm offering banking services in partnership with banks. It offers a mobile platform in the U.S. for accounts, loans, and cards....
-
Immatics N.V. (NASDAQ:IMTX) is a favorite amongst institutional investors who own 50%
By Yahoo! Finance | 3 weeks agoOwnership research and analyst forecasts provide insights into stock opportunities. Institutions own 50% of Immatics N.V. (NASDAQ:IMTX), indicating confidence in its future. Major shareholders like he...
-
Immatics (IMTX): Short Seller Sentiment is Bearish On This ADR Stock
By Yahoo! Finance | 1 month agoThe article discusses the landscape of ADR stocks, focusing on Immatics (NASDAQ:IMTX), a German biopharmaceutical company specializing in cancer immunotherapy. Despite being shorted, the company shows...
-
Investing in MTU Aero Engines (ETR:MTX) a year ago would have delivered you a 66% gain
By Yahoo! Finance | 2 months agoPassive investing in index funds can match market returns, but choosing high-performing stocks like MTU Aero Engines AG can significantly increase returns. Despite a drop in earnings per share, the sh...
-
Aemetis, Inc. (NASDAQ:AMTX) Just Reported And Analysts Have Been Cutting Their Estimates
By Yahoo! Finance | 3 months agoAnalysts were too optimistic on Aemetis, Inc. (AMTX) as the company fell short in Q2 results. Despite revenue miss and increased losses, analysts expect accelerated growth. Price target was raised, in...
-
What Does The Future Hold For Aemetis, Inc. (NASDAQ:AMTX)? These Analysts Have Been Cutting Their Estimates
By Yahoo! Finance | 3 months agoAemetis, Inc. (NASDAQ:AMTX) saw a downgrade in revenue forecasts, signaling a weaker outlook. Analysts now predict a 9.1% increase to US$304m in 2024, down from the previous estimate of US$354m....
-
Shareholders have faith in loss-making Aemetis (NASDAQ:AMTX) as stock climbs 14% in past week, taking five-year gain to 250%
By Yahoo! Finance | 4 months agoAemetis, Inc. (NASDAQ:AMTX) has seen a 17% drop in share price in the last quarter, but over the past five years, the share price has risen by 250%. Revenue growth of 4....
-
Is Now An Opportune Moment To Examine Minerals Technologies Inc. (NYSE:MTX)?
By Yahoo! Finance | 4 months agoMinerals Technologies Inc. (NYSE: MTX) has seen a 10% share price rise recently. Despite being a mid-cap stock, it is considered undervalued with a projected doubling of earnings. Investors are advise...
-
Mozart Therapeutics doses first patients in trial of MTX-101 for autoimmune diseases
By Yahoo! Finance | 5 months agoUS biopharmaceutical company Mozart Therapeutics has initiated Phase Ia/b trial of MTX-101, a potential treatment for autoimmune diseases....
-
Here's Why Immatics N.V.'s (NASDAQ:IMTX) CEO Compensation Is The Least Of Shareholders' Concerns
By Yahoo! Finance | 5 months agoImmatics N.V.'s CEO, Harpreet Singh, has led the company well with a 49% EPS growth in the past three years. Shareholders will consider this performance when voting on executive compensation at the up...